Neuronetics (STIM) EBT Margin (2017 - 2026)
Neuronetics' (STIM) quarterly EBT Margin came in at 8.72% in Q2 2026, up 1759.0% year-over-year from 0.47% in Q2 2025, and up 73.31% quarter-over-quarter from 32.68% in Q1 2026.
Powered by 
Analysis
Neuronetics (STIM) EBT Margin (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported EBT Margin for 10 consecutive years, with 8.72% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin rose 1759.0% year-over-year to 8.72% in Q2 2026; TTM through Jun 2026 was 20.49%, a 2060.0% increase from a year earlier, with the FY2025 full-year figure at 26.72%, up 2916.0% from the prior year.
- EBT Margin was 8.72% for Q2 2026 at Neuronetics, up from 32.68% in the prior quarter.
- Over five years, EBT Margin peaked at 8.72% in Q2 2026 and troughed at 78.37% in Q1 2022.
- A 5-year average of 45.95% and a median of 49.49% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin tumbled 2794 bps in 2024 and soared 4119 bps in 2025, its largest moves.
- Over 5 years, EBT Margin stood at 49.12% in 2022, then surged by 37 bps to 30.87% in 2023, then tumbled by 91 bps to 58.81% in 2024, then surged by 70 bps to 17.62% in 2025, then jumped by 50 bps to 8.72% in 2026.
- The last three EBT Margin figures came in at 8.72% (Q2 2026), 32.68% (Q1 2026), and 17.62% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | 18.32% |
| 10 | Neuronetics | 225.60 Mn | 206.17 Mn | 21.22 Mn | -8.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.72% |
| Mar 31, 2026 | -32.68% |
| Dec 31, 2025 | -17.62% |
| Sep 30, 2025 | -25.54% |
| Jun 30, 2025 | -26.31% |
| Mar 31, 2025 | -40.46% |
| Dec 31, 2024 | -58.81% |
| Sep 30, 2024 | -51.01% |
| Jun 30, 2024 | -63.74% |
| Mar 31, 2024 | -49.87% |
| Dec 31, 2023 | -30.87% |
| Sep 30, 2023 | -56.22% |
| Jun 30, 2023 | -48.23% |
| Mar 31, 2023 | -71.81% |
| Dec 31, 2022 | -49.12% |
| Sep 30, 2022 | -51.61% |
| Jun 30, 2022 | -66.12% |
| Mar 31, 2022 | -78.37% |
| Dec 31, 2021 | -53.08% |
| Sep 30, 2021 | -59.24% |